Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Breast”

957 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 957 results

Early research (Phase 1)UnknownNCT05498597
What this trial is testing

AMT-151 in Patients With Selected Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more
Multitude Therapeutics Inc. 30
Not applicableLooking for participantsNCT04169542
What this trial is testing

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

Who this might be right for
Breast Ductal Carcinoma In SituCOVID-19 InfectionHereditary Breast Carcinoma+1 more
M.D. Anderson Cancer Center 600
Testing effectiveness (Phase 2)Ended earlyNCT00290654
What this trial is testing

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 45
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Not applicableLooking for participantsNCT06350500
What this trial is testing

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma in Situ
Roswell Park Cancer Institute 126
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Early research (Phase 1)Active Not RecruitingNCT03845166
What this trial is testing

XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Who this might be right for
Neoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more
Exelixis 325
Early research (Phase 1)Study completedNCT00245024
What this trial is testing

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 30
Not applicableNot Yet RecruitingNCT07492043
What this trial is testing

Breast Tumour Size Measurement by Field Cycling Imaging

Who this might be right for
Breast CancerDuctal Carcinoma In Situ
University of Aberdeen 12
Testing effectiveness (Phase 2)Ended earlyNCT03979508
What this trial is testing

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
Mayo Clinic 26
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Not applicableLooking for participantsNCT07214532
What this trial is testing

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastReceptors, Estrogen (for ER-positive Requirement)
Natera, Inc. 725
Large-scale testing (Phase 3)Active Not RecruitingNCT01357772
What this trial is testing

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

Who this might be right for
Carcinoma, Intraductal, NoninfiltratingRecurrence, Local NeoplasmBreast Neoplasms+1 more
Andrea DeCensi 500
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT02314156
What this trial is testing

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma In Situ+6 more
Northwestern University 67
Not applicableStudy completedNCT04206891
What this trial is testing

CDH1 Germline Mutations in Lobular Breast Cancer

Who this might be right for
Lobular Breast CarcinomaCDH1 Gene Inactivation
European Institute of Oncology 421
Early research (Phase 1)Looking for participantsNCT07261631
What this trial is testing

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast Cancer+3 more
Novartis Pharmaceuticals 180
Load More Results